STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Alpha Tau Medical (NASDAQ: DRTS), developer of the Alpha DaRT® alpha-radiation cancer therapy, announces CFO Raphi Levy's participation in two major healthcare conferences. Levy will attend the Citi 2024 Global Healthcare Conference on December 3rd in Miami, FL, participating in one-on-one meetings from 8:30 AM to 4:30 PM EST. Additionally, he will join the Piper Sandler 36th Annual Healthcare Conference on December 5th in New York, NY, featuring a fireside chat from 10:00-10:25 AM EST along with one-on-one meetings.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

JERUSALEM, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will participate in the Citi 2024 Global Healthcare Conference on December 3rd, 2024 and the Piper Sandler 36th Annual Healthcare Conference on December 5th, 2024.

Event:Citi 2024 Global Healthcare Conference
Format:1-on-1 Meetings
Date:December 3, 2024
Time:8:30AM – 4:30PM EST
Location:Miami, FL


Event:Piper Sandler 36thAnnual Healthcare Conference
Format:Fireside Chat and 1-on-1 Meetings
Date:December 5, 2024
Time:10:00-10:25AM EST
Location:New York, NY


Please reach out to your Citi and Piper Sandler representatives to schedule 1-on-1 meetings with Mr. Levy.

About Alpha Tau Medical Ltd.

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.

About Alpha DaRT ®

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it.

Investor Relations Contact: IR@alphatau.com


FAQ

When is Alpha Tau Medical (DRTS) participating in the Citi Global Healthcare Conference 2024?

Alpha Tau Medical will participate in the Citi Global Healthcare Conference on December 3rd, 2024, from 8:30 AM to 4:30 PM EST in Miami, FL.

What is Alpha Tau Medical's (DRTS) schedule at the Piper Sandler Healthcare Conference?

Alpha Tau Medical will participate in the Piper Sandler Healthcare Conference on December 5th, 2024, with a fireside chat from 10:00-10:25 AM EST in New York, NY.

Who will represent Alpha Tau Medical (DRTS) at the healthcare conferences in December 2024?

CFO Raphi Levy will represent Alpha Tau Medical at both the Citi Global Healthcare Conference and Piper Sandler Healthcare Conference.

What type of sessions will Alpha Tau Medical (DRTS) participate in at these conferences?

At Citi's conference, they will participate in one-on-one meetings. At Piper Sandler's conference, they will have both a fireside chat and one-on-one meetings.
Alpha Tau Medical Ltd

NASDAQ:DRTS

DRTS Rankings

DRTS Latest News

DRTS Latest SEC Filings

DRTS Stock Data

324.87M
57.16M
32.79%
2.28%
0.11%
Biotechnology
Healthcare
Link
Israel
Jerusalem